Mr. Kenny, age 55, has over 30 years of operational and commercial leadership experience. Mr. Kenny currently is an independent director on the Board of Directors for Quantum Si (QSI: Nasdaq). Mr. Kenny previously served as Meridian Bioscience’s Chief Executive… Read More
Mr. Zackary Irani has been a Director of the Company, and has been serving as the Company’s Chairman of the Board and Chief Executive Officer since April 29, 1997. Prior to that time, Mr. Irani served as the Company’s Vice-President… Read More
Ms. Catherine Coste has served as a Director of the Company since September 2020. Ms. Coste retired from Deloitte and Touche LLP in 2020, where she was a senior partner and served as one of Deloitte’s Life Sciences Industry Executive… Read More
Mr. Allen Barbieri served as an independent outside Director of the Company from October 1999 to August 2020, and from August 2020 to present has served as an Executive Director and as Vice Chairman. Mr. Barbieri also serves as Corporate… Read More
Has served as a Director of the Company since April 2007. Since July 1, 2009, Dr. Emerson has served as Vice Chair for Clinical Programs and Chief of Clinical Pathology at the University of Southern California Keck School of Medicine,… Read More
Mr. David Moatazedi has served as the President and Chief Executive Officer, and as a member of the of Board of Directors of Evolus, Inc. (NASDAQ: EOLS), since May 2018. Evolus is a publicly traded life sciences company headquartered in… Read More